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We report the synthesis, photochemical and photophysical properties and preliminary
studies on biological effect of a new tritolylporphyrin dimer (T–D). Absorption and emis-
sion properties of T–D suggest its possible use in photodynamic therapy. T–D is capable
of singlet oxygen production with 0.8 quantum yield. It also has a high photostability. The
photodynamic properties of the dimer were examined following the growth of SKMEL 188
(human melanoma) cells irradiated with red light (cut off < 630 nm). The surviving frac-
tion of the cells decreased about 3-fold (vs. non-irradiated cells) for an 81 J/cm
2
dose. Our
results suggest that tritolylporphyrine dimer T–D may be an interesting hydrophobic
sensitizer for photodynamic therapy.
For more than 80 years it has been known that
haematoporphyrins cause photosensitivity in
man. The efficacy of tumour photodynamic ther-
apy (PDT) with haematoporphyrin derivatives
(HpDs) as a photosensitizer is now well estab-
lished (Graczyk, 1999).
HpD — related commercial products, partially
purified HpDs known as Photofrin I and
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Photofrin II are approved for medical use in some
countries and have been used to treat thousands
of patients all over the world. Some HpDs were
also used to treat experimental melanoma, mostly
its non-pigmented form (Franken et al., 1985;
Gomer et al., 1985; Phillips et al., 1987; Kecik et
al., 1993), only in a few cases was the HpDs-based
PDT studied using tumours and cells containing
different levels of melanin (Nelson et al., 1988;
Favilla et al., 1995). Both pigmented and non-pig-
mented melanoma cells were affected by light de-
pendent toxicity, but the effect was greater for
non-pigmented cells.
There are some limitations for using Photofrin
II as a photosensitising agent. It is not well de-
fined chemically, it is a mixture of HpDs, and this
makes it difficult to control its photosensitising
properties, distribution in tissues and stability. It
was established some years ago that the most ac-
tive components in HpDs mixtures are dihaema-
toporphyrin ethers and/or esters (Dougerthy et
al., 1984; Graczyk, 1999) known as DHE. This fact
focussed the attention of researchers on the syn-
thesis of some new kinds of porphyrin dimers not
possessing the disadvantages of their predeces-
sors, which would be chemically homogeneous
and more stable. In this work we describe the syn-
thesis of a new (Fig. 1) tritolylporphyrin dimer
(T–D). Some of its photophysical and photochemi-
cal properties essential from a PDT point of view
as well as its phototoxic activity against mela-
noma cells in culture are described.
MATERIALS AND METHODS
Synthesis of porphyrin dimer (T–D). The re-
agents for the reaction were obtained by the con-
ventional method of Adler et al. (1967) by the con-
densation of mixed aromatic aldehydes with
pyrrole in boiling propionic acid. From the reac-
tion mixtures 5-(4-aminophenyl)-10,15,20-tritolyl-
porphyrin (APTP) and 5-(4-carboxyphenyl)-
10,15,20-tritolylporphirin (CPTP) were separated.
The porphyrin dimer was prepared by a proce-
dure similar to that described in the literature
(Faustino et al., 1997). CPTP was converted to
acidic chloride by dissolving it (32 mg) in a mix-
ture of dried toluene (4 cm
3
) and dried pyridine (1
cm
3
) with an excess of thionyl chloride (0.15 cm
3
,
0.21 mmol). The solution was stirred and refluxed
under argon for 2 h. The solvents were evaporated
and the resulting residue was dissolved in chloro-
form (5 cm
3
) in the flask, which was then placed
in an ice-bath and a solution of APTP (31 mg) dis-
solved in chloroform (8 cm
3
) was added dropwise
for 15 min. After about 30 h reaction at room tem-
perature no substrates were observed on TLC
plates (0.2 mm silica gel, chloroform). After that
period the reaction mixture was evaporated to
dryness. The resulting product was dissolved in
chloroform (15 cm
3
) and washed with 2% hydro-
chloric acid, water, 5% sodium hydrogen carbon-
ate and again water. The organic phase was dried
with anhydrous magnesium sulphate and evapo-
rated to dryness. Sixty mg of crude product was
obtained and was purified on a silica gel column
(70–210 mesh, 2  40 cm); a mixture of chloro-
form and methanol (20 :1 v/v) was used as eluent.
The first eluted fraction was the dimer. The purity
of the dimer was checked by TLC (silica gel 0.2
mm plate, chloroform, RF = 0.85). The structure
of the substance was confirmed by using ESI
Mass Spectroscopy,
1
H-NMR and IR. The yield of
the dimer was 50 mg (80%).
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Figure 1. 10,15,20-tritolylporphy-
rin-5-(4-amidophenyl)-[5-(4-phenyl)-
10,15,20-tritolylporphyrin](T–D).
Absorption and fluorescence spectra. Absorp-
tion spectra were recorded with a two-beam
Shimadzu UV-VIS 2101 PC spectrophotometer
and a Hewlett-Packard 8453 diode array spectro-
photometer. Fluorescence spectra were deter-
mined using a computer controlled Spex spectro-
fluorimeter Fluorolog-3, model FL3-22 (Xenon
lamp 450 W). Phosphorescence spectra were mea-
sured using a SPEX 1934D3 phosphorimeter (Xe-
non flash lamp). Fluorescence quantum yield F
(under nitrogen) was measured relative to
tetraphenylporphyrin (TPP), which has the quan-
tum yield of fluorescence in toluene F = 0.1 ±
0.01. Phosphorescence emission spectra in the
range 600–900 nm (excitation in Soret band 421
nm) were recorded in frozen toluene glass (77 K).
Rate constant of triplet state quenching. To
determine the transient absorption spectra and
the rate constants of triplet state decay in the
presence or absence of oxygen an Applied
Photophysics Laser Flash Photolysis spectro-
photometer (model LKS 60, Xenon arc lamp,
150W/CR OFR OSRAM) was used. The absorp-
tion spectrum of the triplet state of T–D in the
range 300–800 nm in toluene and the kinetic
curves of decay of the triplet state of T–D after ex-
citation (Nd:Yag laser, 532 nm) were registered.
The triplet state quenching rate constant was de-
termined according to equation 1:
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where: T(O2), T(N2) indicate the lifetimes of the
T–D triplet state (determined from the decay
curves) in the presence of oxygen and in nitrogen,
respectively; [O2] is the concentration of oxygen in
the system studied (1.81  10
–3
M) (Pineiro et al.,
1998).
Typical results are shown in Fig. 3 and summa-
rised in Table 1.
Quantum yield of singlet oxygen formation.
Preliminary experiments of quantum yield of sin-
glet oxygen formation by T–D were carried out us-
ing PAC (Photoacoustic Calorimetry) (Pineiro et
al.,1998). The quantum yield of singlet oxygen for-
mation was found to be 

1
q
= 0.8, which is a typ-
ical value for this class of compounds.
Photobleaching experiments. Solutions of
T–D in dimethylsulfoxide (Me2SO) (10
–4
M) were
irradiated with an LH313K halogen lamp in air
for different irradiation times: from 1 min to 3 h.
No change in optical spectrum was observed. This
fact indicates that the deactivation of singlet oxy-
gen is of a purely physical nature.
Cytotoxicity assay. To check the cytotoxicity of
T–D, human melanoma cells (SKMEL 188) and
mouse melanoma cells (S91) were incubated for
24 h in phosphate-buffered saline (NaCl/Pi) con-
taining various concentrations of T–D. The
porphyrin dimer was dissolved in Me2SO, then di-
luted in NaCl/Pi to reach different concentrations
of T–D (10
–8
– 10
–5
M). Thereafter the cells were
maintained in F10 (SKMEL) and RPMI (S91) me-
dia with 10% and 5% serum, respectively, for 48 h.
Cytotoxicity in the dark was monitored by count-
ing the number of cells in the treated and un-
treated cultures.
Photodynamic effect measurements. To eval-
uate the influence of T–D-based PDT on cell
growth, the cells in the presence of the
photosensitiser (10
–7
M) were irradiated using an
LH313K lamp with a filter cutting off wave-
lengths below 630 nm. Different doses of energy
between 13.5–82 J/cm
2
(irradiation time: 5–30
min) were used. After irradiation, cells were incu-
bated in the culture medium for 36 h. The surviv-
ing fraction was monitored by counting the num-
ber of PDT treated and untreated cells. Data
points are the means of two or more experiments.
Bars represent standard error (±S.E.M.).
RESULTS AND DISCUSSION
It is now recognised that an adequate photo-
sensitising agent should posses specific chemical
and biological properties. It should be easy to syn-
thesise, relatively stable, exhibit minimal dark
toxicity, have a substantial absorbance band
above 600 nm and an efficient yield of singlet oxy-
gen generation. It should also be a chemically
pure substance. Of course, decisive are always the
results of biological experiments, showing the
ability of the compound to generate light induced
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cell toxicity. We present and discuss the results
from this point of view.
Synthesis of porphyrin dimer (T–D)
The synthesis of T–D proceeds with sufficient ef-
ficiency (80%). The isolation and purification of
the compound is relatively simple and cheap. The
product obtained is homogeneous, chemically well
defined, and is not a mixture of many porphyrins,
which is an advantage in relation to Photofrin II.
Photophysics and photochemistry of porphyrin
dimer
The relevant data obtained from absorption and
fluorescence spectra as well as from laser flash
photolysis of T–D are summarised in Table 1,
Figs. 2 and 3. In the concentration range used in
the spectroscopic and biological studies the Lam-
bert-Beer law (measured in toluene) was obeyed
and the tendency to aggregate was not found.
This fact does not exclude the possibility of aggre-
gation inside the cells, which is often found for
this kind of compounds. For T–D the strongest
absorption band is, like for other porphyrins, near
400 nm (423 nm, 423 = 4.73  10
5
M
–1
cm
–1
),
and there are additional bands with progressively
decreasing absorbance at 517, 552, 592, and 649
nm. The last absorption band at 649 nm is the
most important regarding PDT, because only the
red light has sufficient tissue penetration ability
(Wilson et al., 1985). The absorption coefficient of
T–D at this wavelength is not very high, 649 =
7.55  10
3
M
–1
cm
–1
, but it is sufficient to absorb
the light effectively. Other porphyrins have simi-
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Table 1. Some photophysical and photochemical data of T–D (toluene, room temperature, air).
Wavelength used for PDT
molar absorption coefficient
 = 649 nm;
649 = 7.55  10
3
M
–1
cm
–1
First excited singlet state energy ES = 183.2  0.3 kJ  mol
–1
Maximum of fluorescence
quantum yield of fluorescence
max
F
= 652 nm;
F = 0.11  0.01
Rate constant of triplet state quenching kq = 1.74  10
9
 1.25  10
5
M
-1
s
–1
Triplet state life-times:
in the presence of oxygen (1.8110
-3
M)
in deaerated toluene
(O2) = 312  9.8 ns
(N2)  19  10
3
ns
Singlet oxygen generation yield 

1
q
= 0.8
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Figure 2. UV-VIS absorption spec-
trum of T–D in toluene at 510
–6
M.
The wavelengths above 630 nm were used
in PDT experiments. Inset: Long-wave-
length part of the absorption spectrum of
T–D (broken line) and the fluorescence
spectrum of T–D in toluene (solid line).
The observed Stokes’ shift is small, about
3 nm.

lar values of absorption coefficients at these wave-
lengths. The spectroscopic singlet-state energy
(Es, Table 1) was obtained using standard proce-
dure, from the intersection of normalised absorp-
tion and fluorescence spectra (Fig. 2 — inset). The
fluorescence quantum yield of T–D in deaerated
toluene is F = 0.11 ± 0.01, which is a reasonable
value for a sensitizer to be used in PDT. The shape
of the transient absorption spectrum and the rate
constant of its decay strongly suggest the triplet
state origin. All triplet state decay curves (Fig. 3)
are independent of the monitoring wavelength
and reveal the same type of monoexponential ki-
netics. The life-times of the triplet state in the
presence and absence of oxygen, as well as the
rate constant of its quenching by oxygen (

1
q
),
were calculated according to the procedure de-
scribed in Methods (mean values are shown in Ta-
ble 1). The presented photochemical and photo-
physical data of T–D are similar to the data for
other porphyrins (Pineiro et al., 1998; Faustino et
al., 1997; Graczyk,1999).
Bioassay
The photosensitising efficiency of T–D is shown
in Fig. 4. The surviving fraction of the human mel-
anoma cells (SKMEL 188) decreased almost 3-fold
(versus untreated cells) with an energy dose 81
J/cm
2
. The results for mouse melanoma cells
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Figure 3. Typical decay curve of the
triplet state of T–D in toluene.
Inset: Typical transient absorption spec-
trum of T–D in toluene after 100 ns since
the exciting pulse (excitation wave  = 532
nm, A532 = 0.1). In addition to the bands
connected with absorption by the triplet
state of T–D, some bands with negative
values of absorbance connected with de-
population in the ground state were ob-
served. All experiments were carried out
at room temperature (approx. 22C).
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Figure 4. Effect of photo-
dynamic treatment [B]
with T–D as the sensi-
tizer on survival of
SKMEL 188 cells.
Cells were treated with T–D
(10
–7
M) illuminated with
the indicated dose (J/cm
2
)
and further incubated in
growth medium in the dark
for 48 h. Light control [A]
the cells were illuminated
without T–D. In the inset
the cytotoxicity of T–D in
the dark is presented [C].
(S91) were almost the same (data not shown).
Light alone caused small changes in the surviving
fraction of the cells (Fig. 4, curve A). The toxicity
of the dimer in the dark is presented in Fig. 4
(curve C). The concentration of T–D of 10
–7
M
was chosen as sublethal and used for the PDT ex-
periment. Comparing our bioassay results to the
others, which used HpDs or Photofrin as
photosensitising agents (Penning et al., 1994;
Chang et al., 1999) one can see that we obtained a
comparable photokilling effect using a signifi-
cantly lower dye concentration (30-fold) and irra-
diation dose (2-fold).
The newly synthesised photosensitizer T–D has
quite a lot of advantages compared to HpDs being
in use to date. Chemical homogeneity, low ten-
dency to aggregate, good solubility in hydropho-
bic phases with a relatively long-living triplet state
to generate sufficient singlet oxygen quantities
(

1
q
= 0.8) make T–D an effective compound
acting via the classical kind II photokilling mecha-
nism.
Our compound also has some disadvantages,
common for all HpDs: a relatively small extinction
coefficient around 630 nm lowers the
photoexcitation, thus requiring the administra-
tion of large amounts of energy in order to obtain
a satisfactory phototherapeutic response. How-
ever, the above-mentioned photochemical fea-
tures of T–D and its behaviour in the PDT experi-
ment in vitro permit us to finally conclude that
this porphyrin dimer is a promising candidate for
a new PDT-agent and is worth further investiga-
tions, especially in vivo.
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